Strategy to obtain warfarin or direct oral anticoagulant's benefit by evaluating registry: Strawberry study
Not Applicable
- Conditions
- atrial fibrillation
- Registration Number
- JPRN-UMIN000025721
- Lead Sponsor
- Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 235
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with valvular atrial fibrillation 2. Patients unable to undergo MRI examination, or MRI cannot be evaluated due to body movement, etc. 3. Patients with dementia with a CDR global score greater than or equal to 1 or MMSE less than 20 4. 6 months or less since occurrence of stroke 5. Less than or equal to 6 years of education 6. Judged by an investigator to be ineligible to participate as a study subject
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in MMSE from time of enrollment until 3 years after enrollment
- Secondary Outcome Measures
Name Time Method 1. Change in Montreal Cognitive Assessment (MoCA) from time of enrollment until 3 years after enrollment 2. Time until occurrence of any death, stroke, or cardiovascular event 3. Change in CDR global score from time of enrollment until 3 years after enrollment 4. Change in Clinical Dementia Rating Sum of Boxes (CDR-SB) score from time of enrollment Time until hemorrhagic or ischemic event